Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients

Infectious Disease Clinics of North America

Volumn 10, Issue 2, 1996, Pages 365-400

  Walsh, T J ^a   Hiemenz, J W ^a   Anaissie, E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CLOTRIMAZOLE; CORTICOSTEROID; CYCLOSPORIN; CYTOTOXIC AGENT; ERYTHROPOIETIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; NYSTATIN; PARACETAMOL; PETHIDINE; RIFAMPICIN; UNINDEXED DRUG;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANEMIA; ASPERGILLOSIS; BONE MARROW SUPPRESSION; CANCER; CANDIDIASIS; CHILL; CLINICAL TRIAL; CRYPTOCOCCOSIS; DISEASE PREDISPOSITION; DRUG FORMULATION; FEVER; FUSARIUM; HEADACHE; HOST RESISTANCE; HUMAN; MALASSEZIA FURFUR; MUCORMYCOSIS; MYCOSIS; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PHAEOHYPHOMYCOSIS; REVIEW; RIGOR; STEVENS JOHNSON SYNDROME; TRICHOSPORON; VERTIGO; VOMITING;

EID: 0029933706     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70303-2     Document Type: Article

References (180)

1. M. Allende M. Horowitz H.I. Pass Pulmonary cryptococcosis presenting as metastases in children with sarcoma Pediatr Infect Dis J 12 1993 240
2. M.C. Allende J.W. Lee P. Francis Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion (ABCD) in experimental pulmonary aspergillosis Antimicrob Agents Chemother 38 1994 518
3. M.A. Amantea R.A. Bowden A. Forrest Population pharmacokinetics and renal function-sparing effects of amphotericin B colloidal dispersion in patients receiving bone marrow transplants Antimicrob Agents Chemother 39 1995 2042
4. American Society of Clinical Oncology Recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines J Clin Oncol 12 1994 2471
5. E. Anaissie G.P. Bodey H. Kantarjian Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy Am J Med 91 1991 142
6. E.J. Anaissie S. Vartivarian G.P. Bodey Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony stimulating factor (E. coli-derived) in cancer patients with fever and neutropenia Am J Med 100 1996 17
7. Anaissie EJ, White M, Uzun C, et al: Amphotericin B lipid complex (ABLC) versus amphotercin B for treatment of hematogenous and invasive candidiasis: A prospective, randomized, multicenter trial. Abstracts of the 35th ICAAC, p 330, LM21, 1995
8. E. Anaissie H. Kantarjian J. Ro The emerging role of Fusarium infections in patients with cancer Medicine 67 1988 77
9. E. Anaissie Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review Clin Infect Dis Suppl 1 1992 S43
10. E. Anaissie G.P. Bodey H. Kantarjian New spectrum of fungal infections in patients with cancer Rev Infect Dis 11 1989 369
11. E. Anaissie A. Gokaslan R. Hachem Azole therapy for trichosporonosis: Clinical evaluation of eight patients, experimental therapy for murine infection, and review Clin Infect Dis 15 1992 781
12. E.J. Anaissie R. Hachem N.C. Karyotakis Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis Antimicrob Agents Chemother 38 1994 2541
13. E. Anaissie H. Pinczowski Invasive candidiasis during granulocytopenia Recent Results Cancer Res 132 1993 137
14. E.J. Anaissie N.C. Karyotakis R. Hachem Correlation between in vitro and in vivo activity of antifungal agents against Candida species J Infect Dis 170 1994 384
15. E.J. Anaissie D.P. Kontoyiannis C. Huls Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections J Infect Dis 172 1995 599
16. Anaissie EJ, Vartivarian SE, Abi-Said D, et al: Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: A matched cohort study. Am J Med, in press
17. D. Armstrong Problems in management of opportunistic fungal infections Rev Infect Dis 11 suppl 7 1989 S1591
18. C.A.S. Arndt T.J. Walsh C.L. McCully Fluconazole penetration into cerebrospinal fluid: Implications for treating fungal infections of the central nervous system J Infect Dis 157 1988 178
19. T.J. Barloon J.R. Galvin M. Mori High-resolution ultrafast chest CT in the clinical management of febrile bone marrow transplant patients with normal or nonspecific roentgenograms Chest 99 1991 928
20. J. Berenguer J. Diaz-Mediavilla D. Urra Central nervous system infection caused by Pseudallescheria boydii : Case report and review Rev Infect Dis 11 1990 890
21. J. Berenguer N. Ali M.C. Allende Itraconazole in experimental pulmonary aspergillosis: Comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole plasma concentrations Antimicrob Agents Chemother 38 1994 1303
22. J. Berenguer M.C. Allende J.W. Lee Pathogenesis of invasive pulmonary aspergillosis during persistent granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression Am J Respir Crit Care Med 152 1995 1079
23. J. Berenguer M. Buck F. Witebsky Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis: Disseminated versus single organ infection Diagnostic Microbiol Infect Dis 17 1993 103
24. J. Berenguer P. Munoz F. Parras Treatment of deep mycoses with liposomal amphotericin B Eur J Clin Microbiol Infect Dis 13 1994 504
25. J. Bille R. Edson G. Roberts Clinical evaluation of the lysis centrifugation blood culture system for the detection of fungemia and comparison with a conventional biphasic broth blood culture system J Clin Microbiol 19 1984 126
26. G.P. Bodey M. Luna Skin lesions associated with disseminated candidiasis JAMA 229 1974 1466
27. G.P. Bodey E. Anaissie J. Gutterman Role of granulocyte-macrophage colony stimulating factor as adjuvant therapy for fungal infection in patients with cancer Clin Infect Dis 17 1993 705
28. G.P. Bodey Dermatologic manifestations of infections in neutropenic patients Infect Dis Clin North Am 8 1994 655
29. G.P. Bodey E.J. Anaissie Chronic systemic candidiasis Eur J Clin Microbiol Infect Dis 8 1989 855
30. G.P. Bodey E.J. Anaissie L.S. Elting Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B Cancer 73 1994 2099
31. G.P. Bodey The potential role of granulocyte-macrophage colony stimulating factor in therapy of fungal infections: A commentary [editorial] Eur J Clin Microbiol Infect Dis 13 1994 363
32. G.P. Bodey Candidiasis in cancer patients Am J Med 77 suppl 1984 13
33. K.W. Brammer Management of fungal infection in neutropenic patients with fluconazole Hematol Bluttransfus 33 1990 546
34. K.W. Brammer P.E. Coates The pharmacokinetics of fluconazole in children Eur J Clin Microbiol Infect Dis 13 1994 325
35. R.A. Branch Prevention of amphotericin B-induced renal impairment: A review on the use of sodium supplementation Arch Intern Med 148 1988 2389
36. S.J. Brandt R.A. Peters K. Waters Effect of recombinant human granulocyte-macrophage colony stimulating factor on hematopoietic reconstitution after high dose of chemotherapy and autologous bone marrow transplantation N Engl J Med 318 1988 869
37. G.E. Buck V. Hanes M.T. Kelly Clinical comparison of the Roche Septi-Chek and DuPont Isolator blood culture systems Am J Clin Pathol 87 1987 396
38. P.A. Burch J.E. Karp W.G. Merz Favorable outcome of invasive aspergillosis in patients with acute leukemia J Clin Oncol 5 1987 1985
39. A. Catanzaro J.N. Galgiani B.E. Levine Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Am J Med 98 1995 249
40. R. Chopra S. Blair J. Strang Liposomal amphotericin B (AmBisome) in treatment of fungal infections in neutropenic patients J Antimicrob Chemother 28 suppl B 1991 93
41. J.M. Clark R.R. Whitney S.J. Olsen Amphotericin B lipid complex therapy of experimental fungal infections in mice Antimicrob Agents Chemother 35 1991 615
42. E. Conneally M.T. Cafferkey P.A. Daly Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients Bone Marrow Transplant 5 1990 403
43. M.A. Crislip J.E. Edwards Candidiasis Infect Dis Clin North Am 3 1989 103
44. A.L. Daly L.A. Velazquez S.F. Bradley Mucormycosis: Association with deferoxamine therapy Am J Med 87 1989 468
45. V. Dato A. Dajani Candidemia in children with central venous catheters: Role of catheter removal and amphotericin B therapy Pediatr Infect Dis J 9 1990 309
46. F. De Bernardis C. Girmenia M. Boccanera Use of a monoclonal antibody in a dot immunobinding assay for detection of a circulating mannoprotein of Candida spp. in neutropenic patients with invasive candidiasis J Clin Microbiol 31 1993 3142
47. D. Denning D.A. Stevens Antifungal and surgical treatment of invasive aspergillosis: Review of 2,121 published cases Rev Infect Dis 12 1990 1147
48. D.W. Denning J.Y. Lee J.S. Hostetler NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis Am J Med 97 1994 135
49. D.W. Denning R.M. Tucker L.H. Hanson Itraconazole therapy for cryptococcal meningitis and cryptococcosis Arch Intern Med 149 1989 2301
50. D.M. Dixon T.J. Walsh W.G. Merz Human central nervous system infections due to Xylohypha bantiana (Cladosporium trichoides) 11 1989 515
51. B. Dupont M. Huber S.J. Kim Galactomannan antigenemia and antigenuria in aspergillosis: Studies in patients with experimentally infected rabbits J Infect Dis 155 1987 1
52. EORTC International Antimicrobial Therapy Cooperative Group Empiric antifungal therapy in febrile granulocytopenic patients Am J Med 86 1989 668
53. A. Espinel-Ingroff K. Dawson M. Pfaller Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi Antimicrob Agents Chemother 39 1995 314
54. R.C. Fader M.R. McGinnis Infections caused by dematiaceous fungi: Chromoblastomycosis and phaeohyphomycosis Infect Dis Clin North Am 2 1988 925
55. G. Foulds D.R. Brennan C. Wajszczuk Fluconazole penetration into cerebrospinal fluid in humans J Clin Pharm 28 1988 363
56. P. Francis T.J. Walsh The evolving role of flucytosine in immunocompromised patients: New insights into safety, pharmacokinetics, and antifungal therapy Rev Infect Dis 15 1992 1003
57. P. Francis J.W. Lee A. Hoffman Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: The potential role of bronchoalveolar lavage D-mannitol and galactomannan as markers of infection J Infect Dis 169 1994 356
58. P. Francis T.J. Walsh Management of fungal infections in cancer patients. Parts I & II Oncology 6 1992 81 133
59. G. Gentile A. Micozzi C. Girmenia Pneumonia in allogenic and autologous bone marrow recipients. A retrospective study Chest 104 1993 371
60. D. George D. Kordick P. Miniter Combination therapy in experimental invasive aspergillosis J Infect Dis 168 1993 692
61. N.H. Georgopapadakou T.J. Walsh Human mycoses: Drugs and targets for emerging pathogens Science 264 1994 371
62. C. Girmenia V. Donato A.P. Iori Spontaneous pneumothorax in patients with leukemia: first sign of invasive mycosis? Universita degli Studi La Sapienza, Rome, Italy Ann Intern Med 118 1993 707
63. J.L. Goodman D.J. Winston R.A. Greenfield A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation N Engl J Med 326 1992 845
64. S.M. Grant S.P. Clissold Fluconazole: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses Drugs 39 1990 877
65. L. Guerra-Romero R.S. Edson F.R. Cockerill III Comparison of DuPont Isolator and Roche Septi-chek for detection of fungemia J Clin Microbiol 25 1987 1623
66. T.C. Hardin J.R. Graybill R. Fetchick Pharmacokinetics of itraconazole following oral administration to normal volunteers Antimicrob Agents Chemother 32 1988 1310
67. E. Haron S. Vartivarian E. Anaissie Primary Candida pneumonia. Experience at a large cancer center and review of the literature Medicine 72 1993 137
68. H.T. Heidemann J.F. Gerkens W.A. Spickard Amphotericin B nephrotoxicity in humans decreased by salt repletion Am J Med 75 1983 476
69. Hiemenz JW, Walsh TJ: Lipid formulations of amphotericin B: Recent progress and future directions. Clin Infect Dis, in press
70. J.W. Hiemenz J.N. Greene Special considerations for the patient undergoing allogeneic or autologous bone marrow transplantation Hematol Oncol Clin North Am 7 1993 961
71. W.T. Hughes P.A. Pizzo J.C. Wade Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients Clin Infect Dis 16 1993 341
72. F.W. Kahn J.M. Jones D.M. England The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis Am J Clin Pathol 86 1986 518
73. V.L. Kan Polymerase chain reaction for the diagnosis of candidemia J Infect Dis 168 1993 779
74. J.E. Karp P.A. Burch W.G. Merz An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis Am J Med 85 1988 203
75. N.C. Karyotakis E.J. Anaissie R. Hachem Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice J Infect Dis 168 1993 1311
76. C.A. Kauffman S.F. Bradley S.C. Ross Hepatosplenic candidiasis: Successful treatment with fluconazole Am J Med 91 1991 137
77. S. Klotz Malassezia furfur Infect Dis Clin North Am 3 1988 53
78. S.R. Knoper J.N. Galgiani Coccidioidomycosis Infect Dis Clin North Am 2 1988 861
79. D.P. Kontoyianis S. Vartivarian E.J. Anaissie Infections due to Cunninghamella bertholletiae in patients with cancer: Report of three cases and review Clin Infect Dis 18 1994 925
80. J.E. Kuhlman The role of chest CT in evaluation of the febrile bone marrow transplant recipient Chest 99 1991 794
81. J.E. Kuhlman E.K. Fishman P.A. Burch Invasive pulmonary aspergillosis in acute leukemia: The contribution of CT to early diagnosis and aggressive management Chest 92 1987 95
82. B.J. Kullberg J.W. van 't Wout Cytokines in the treatment of fungal infections Biotherapy 7 1994 195
83. J.D. Lazar K.D. Wilner Drug interactions with fluconazole Rev Infect Dis 12 suppl 3 1990 S327
84. J.A. Lecciones J.W. Lee E. Navarro Vascular catheter-associated fungemia in cancer patients: Analysis of 155 episodes Rev Infect Dis 14 1992 875
85. J.W. Lee N.I. Seibel M.A. Amantea Safety, tolerance, and pharmacokinetics of fluconazole in children with neoplastic diseases J Pediatr 120 1992 987
86. J.W. Lee M. Amantea E. Navarro Pharmacokinetics and safety of a unilamellar formulation of liposomal amphotericin B (AmBisome) in rabbits Antimicrob Agents Chemother 38 1994 713
87. R.J. Leggiadro F.F. Barrett W.T. Hughes Extrapulmonary cryptococcosis in immunocompromised infants and children Pediatr Infect Dis J 11 1992 43
88. S.J. Levine T.J. Walsh A. Martinez Hypoxemia, pulmonary hypertension, and depression of cardiac output as sequelae of liposomal amphotericin B infusion Ann Intern Med 114 1991 664
89. G. Lopez-Berestein Treatment of hepatosplenic candidiasis with liposomal amphotericin B J Clin Oncol 5 1987 310
90. G. Lopez-Berestein V. Fainstein R. Hopfer Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: A preliminary study J Infect Dis 151 1985 704
91. G. Lopez-Berestein Liposomes in infectious diseases: Present and future Curr Clin Top Infect Dis 10 1989 241
92. G. Lopez-Berestein Liposomal amphotericin B in the treatment of fungal infections Ann Intern Med 105 1986 130
93. C. Lyman T.J. Walsh Systemically administered antifungal agents: A review of clinical pharmacology and therapeutic applications Drugs 44 1992 9
94. C.A. Lyman K.F. Garrett P.A. Pizzo Response of human polymorphonuclear leukocytes and monocytes to Trichosporon beigelii : Host defense against an emerging pathogen J Infect Dis 170 1994 1557
95. P. Martino M. Venditti A. Micozzi Blastoschizomyces capitatus : An emerging cause of invasive fungal disease in leukemia patients Rev Infect Dis 12 1990 570
96. P. Martino R. Gastaldi R. Raccah Clinical patterns of Fusarium infections in immunocompromised patients J Infect suppl 1 1994 7
97. P. Martino C. Girmenia A. Micozzi Fungemia in patients with leukemia Am J Med Sci 306 1993 225
98. T. Matsumoto L. Ajello T. Matsuda Developments in phaeohyphomycosis and hyalohyphomycosis J Med Vet Mycol 32 suppl 1 1994 329
99. R.E. McCabe R.G. Brooks J.B.D. Mark Open lung biopsy in patients with acute leukemia Am J Med 78 1985 609
100. G. McDonald P. Sharma R. Hackman Infectious esophagitis in immunosuppressed patients after marrow transplantation Gastroenterology 88 1985 1111
101. T. Mehta G. Lopez-Berestein R. Hopfer Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells Biochemica et Biophysica Acta 770 1984 230
102. W.J. Melchers P.E. Verweij P. van den Hurk General primer-mediated PCR for detection of Aspergillus species J Clin Microbiol 32 1994 1710
103. K.A. Melez J. Cherry C. Sanchez Successful outpatient treatment of Trichosporon beigelii peritonitis with oral fluconazole Pediatr Infect Dis J 14 1995 1110
104. F. Menichetti A. Del Favero P. Martino Preventing fungal infection in neutropenic patients with acute leukemia: Fluconazole compared with oral amphotericin B. The GIMEMA Infection Program Ann Intern Med 120 1994 913
105. W. Merz J. Karp M. Hoagland Diagnosis and successful treatment of fusariosis in the compromised host J Infect Dis 158 1988 1046
106. W.G. Merz S. Kodsy C.S. Merz Recovery of Histoplasma capsulatum from blood in a commercial radiometric Mycobacterium medium J Clin Microbiol 30 1992 237
107. F. Meunier M. Aoun M. Gerard Therapy for oropharyngeal candidiasis in the immunocompromised host: A randomized double-blind study of fluconazole vs. ketoconazole Rev Infect Dis 12 suppl 3 1990 S364
108. F. Meunier Fluconazole treatment of fungal infections in the immunocompromised host Semin Oncol 17 suppl 6 1990 19
109. F. Meunier New methods for delivery of antifungal agents Rev Infect Dis 11 suppl 7 1989 s1605
110. G. Morstyn L. Campbell L. Souza Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy Lancet 2 1988 667
111. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed Standard. NCCLS document M27-P. NCCLS, Villanova, PA, 1992
112. P.E. Nelson M.C. Dignani E.J. Anaissie Taxonomy, biology, and clinical aspects of Fusarium species Clin Microbiol Rev 7 1994 479
113. J. Neumanaitis J.D. Meyers C.D. Buckner Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections Blood 4 1991 907
114. I. Novakova P. Donnelly T. DeWitte Itraconazole and cyclosporin nephrotoxicity Lancet 2 1987 920
115. R.J. Panos L.F. Barr T.J. Walsh Factors associated with fatal hemoptysis in cancer patients Chest 94 1988 1008
116. J.R. Perfect D.T. Durack Penetration of imidazoles and triazoles into cerebrospinal fluid in rabbits J Antimicrob Chemother 16 1985 81
117. J. Perfect Crytpococcosis Infect Dis Clin North Am 3 1989 77
118. P.A. Pizzo K.J. Robichaud F.A. Gill Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia Am J Med 72 1982 101
119. W.G. Powderly M.S. Saag G.A. Cloud A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome N Engl J Med 326 1992 793
120. A. Reuben E. Anaissie P.E. Nelson Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method Antimicrob Agents Chemother 33 1989 1647
121. J.H. Rex J.E. Bennett A.M. Sugar A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia N Engl J Med 331 1994 1325
122. J.H. Rex J.E. Bennett A.M. Sugar Intravascular catheter exchanges and the duration of candidemia Clin Infect Dis 21 1995 994
123. H.M. Richet A. Andremont Tancrede Risk factors for candidemia in patients with acute lymphocytic leukemia Rev Infect Dis 13 1991 211
124. M. Rinaldi Zygomycosis Infect Dis Clin North Am 3 1989 19
125. O. Ringden F. Meunier J. Tollemar Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients J Antimicrob Chemother 28 suppl B 1991 63
126. M.J. Robertson R.A. Larson Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy Am J Med 84 1988 233
127. E. Roilides P.A. Pizzo Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts 15 1992 508
128. E. Roilides A. Holmes C. Blake Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: Enhancement by granulocyte-macrophage colony-stimulating factor and interferon-γ J Infect Dis 170 1994 894
129. E. Roilides T. Sein A. Holmes Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus J Infect Dis 172 1995 1028
130. F. Rossetti D.L. Brawner R. Bowden Fungal liver infection in marrow transplant recipients: Prevalence at autopsy, predisposing factors, and clinical features Clin Infect Dis 20 1995 801
131. S.R. Rousey S. Russler M. Gottlieb Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation Am J Med 91 1991 484
132. J.M. Rowe J.W. Andersen J.J. Mazza A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients > 55 to 70 years of age) with acute myelogenous leukemia: A study of the Eastern Cooperative Oncology Group (E1490) Blood 86 1995 457
133. H. Saito E.J. Anaissie R.C. Morice Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia Chest 94 1988 745
134. A. Schaffner H. Douglas A. Braude Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus J Clin Invest 69 1982 617
135. A. Schaffner M. Schaffner Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias J Infect Dis 172 1995 1035
136. P.K. Sharkey J.R. Graybill M.G. Rinaldi Itraconazole treatment of phaeohyphomycosis J Am Acad Dermatol 23 1990 577
137. M.A. Slavin B. Osborne R. Adams Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation—A prospective, randomized, double-blind study J Infect Dis 171 1995 1545
138. R.E. Soay T.A. Larson J.P. Toscano Pharmacokinetics of fluconazole in immunecompromised children with leukemia or other hematologic disease Pharmacotherapy 15 1995 52
139. K. Supparatpinyo C. Khamwan V. Baosoung Disseminated Penicillium marneffei infection in southeast Asia Lancet 344 8915 1994 110
140. F.C. Szoka Jr D. Milholland M. Barza Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B Antimicrob Agents Chemother 31 1987 421
141. G.H. Talbot M.H. Weiner S.L. Gerson Serodiagnosis of invasive aspergillosis in patients with hematologic malignancy: Validation of the Aspergillus fumigatus antigen radioimmunoassay J Infect Dis 155 1987 12
142. M. Thaler B. Pastakia T.H. Shawker Hepatic candidiasis in cancer patients: The evolving picture of the syndrome Ann Intern Med 108 1988 98
143. J. Tollemar O. Ringden S. Andersson Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: A randomized trial in bone marrow transplant recipients Transplant Proc 25 1993 1495
144. T.R. Treger D.W. Visscher M.S. Bartlett Diagnosis of pulmonary infection caused by Aspergillus : Usefulness of respiratory cultures J Infect Dis 152 1985 572
145. D. Trenk W. Brett E. Jahnchen Time course of cyclosporine/itraconazole interaction Lancet 2 1987 1335
146. G. Tricot E. Joosten M.A. Boogaerts Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies Rev Infect Dis 9 suppl 1 1987 94
147. H. van den Bossche Biochemical targets for antifungal azole derivatives: Hypothesis on the mode of action M. McGinnis Current Topics in Medical Mycology 1985 Springer-Verlag New York 313 351
148. S.E. Vartivarian E.J. Anaissie G.P. Bodey Emerging fungal pathogens in immunocompromised patients: Classification, diagnosis, and management Clin Infect Dis 17 suppl 2 1993 S487
149. P.E. Verweij D. Stynen A.J. Rijs Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients J Clin Microbiol 33 1995 1912
150. C. Viscoli E. Castagnola F. Fioredda Fluconazole in the treatment of candidiasis in immunocompromised children Antimicrob Agents Chemother 35 1991 365
151. T.J. Walsh C. Bustamente D. Vlahov Candida suppurative peripheral thrombophlebitis: Prevention, recognition and management Infection Control 7 1986 16
152. T.J. Walsh L.R. Caplan D.B. Hier Aspergillus infections of the central nervous system: A clinicopathological analysis Ann Neurol 18 1985 574
153. T.J. Walsh D.M. Dixon Nosocomial aspergillosis: Environmental microbiology, hospital epidemiology, diagnosis, and treatment Eur J Epidemiol 5 1989 131
154. T.J. Walsh A. Francesconi M. Kasai Polymerase chain reaction and single strand conformational polymorphism (SSCP) for recognition of medically important opportunistic fungi J Clin Microbiol 33 1995 3216
155. T.J. Walsh K. Garrett E. Feuerstein Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography: A novel non-invasive method for measuring responses of organism-mediated tissue injury Antimicrob Agents Chemother 39 1995 1065
156. T.J. Walsh D.B. Hiem L.R. Caplan Fungal infections of the central nervous system: Analysis of risk factors and clinical manifestations Neurology 35 1985 1654
157. T.J. Walsh J. Hiemenz P.A. Pizzo Evolving risk factors for invasive fungal infections: All neutropenic patients are not the same Clin Infect Dis 18 1994 793
158. Walsh TJ, Hiemenz JW, Seibel N, et al: Amphotericin B lipid complex in the treatment of 228 cases of invasive mycosis. Abstracts of the 34th ICAAC. Orlando, October 4-7, 1994, p 247, abstr M69
159. T.J. Walsh J. Lee S. Aoki Experimental basis for usage of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts Rev Infect Dis 12 1990 307
160. T.J. Walsh J. Lee J. Lecciones Empirical amphotericin B in febrile granulocytopenic patients Rev Infect Dis 13 1991 496
161. T.J. Walsh J.W. Lee G.P. Melcher Experimental disseminated trichosporonosis in persistently granulocytopenic rabbits: Implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic infection J Infect Dis 166 1992 121
162. T.J. Walsh G. Melcher M. Rinaldi Trichosporon beigelii: An emerging pathogen resistant to amphotericin B J Clin Microbiol 28 1990 1616
163. T.J. Walsh G.P. Melcher J.W. Lee Infections due to Trichosporon species: New concepts in mycology, pathogenesis, diagnosis, and treatment Curr Top Med Mycol 5 1993 79
164. T.J. Walsh C. Monzalez C.A. Lyman Invasive fungal infections in children: Recent advances in diagnosis and treatment Advances in Pediatr Infect Dis 11 1995 187
165. T.J. Walsh W.G. Merz J.W. Lee Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol Am J Med 99 1995 164
166. T.J. Walsh J. Peter D.A. McGough Activity of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii Antimicrob Agents Chemother 39 1995 1361
167. T.J. Walsh G. Renshaw J. Andrews Invasive zygomycosis due to Conidiobolus incongruus Clin Infect Dis 19 1994 423
168. T.J. Walsh N. Relitsos S.R. Hamilton Bacterial esophagitis in immunocompromised patients Arch Intern Med 146 1986 1345
169. T.J. Walsh P.O. Whitcomb S. Ravankar Successful treatment of hepatosplenic candidiasis through repeated episodes of neutropenia Cancer 76 1995 2357
170. T.J. Walsh C.A. Wyman P.A. Pizzo Laboratory diagnosis of invasive fungal infections in patients with neoplastic diseases Bailliere's Clin Infect Dis 2 1995 25
171. Walsh TJ, Yekersky I, Yeldandi V, et al: Pharmacokinetics of AmBisome in persistently febrile neutropenic patients receiving empirical antifungal therapy. Abstracts of the 35th ICAAC. San Francisco, September 17-20, 1995, p 13, abstr A11
172. R.H. Weisbart Colony-stimulating factors and neutrophils. Colony stimulating-factors and host defense Ann Intern Med 11 1989 297
173. L.J. Wheat Histoplasmosis Infect Dis Clin North Am 2 1988 841
174. J. Wheat R. Hafner A.H. Korzun Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome Am J Med 98 1995 336
175. J. Wiley Invasive fungal infections in children with cancer J Clin Oncol 8 1990 280
176. J.R. Wingard W.G. Merz M.G. Rinaldi Increase in Candida krusei infections in bone marrow transplant recipients given fluconazole prophylaxis N Engl J Med 325 1991 1274
177. J.R. Wingard Infections in allogeneic bone marrow transplant recipients Semin Oncol 20 suppl 6 1993 80
178. D.J. Winston P.H. Chandrasekar H.M. Lazarus Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial Ann Intern Med 118 1993 495
179. D.G. Wright K.J. Robichaud P.A. Pizzo Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions N Engl J Med 304 1981 1185
180. V.L. Yu R.R. Muder A. Poorsattar Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results of a three-year prospective study Am J Med 81 1986 249